Drug Profile
Tadalafil/tamsulosin - Ildong Pharmaceutical
Latest Information Update: 19 Feb 2022
Price :
$50
*
At a glance
- Originator Ildong Pharmaceutical
- Class Amines; Benzene derivatives; Benzodioxoles; Carbolines; Erectile dysfunction therapies; Ethers; Indoles; Pyridones; Small molecules; Sulfonamides; Vasodilators
- Mechanism of Action Alpha-1a adrenergic receptor antagonists; Type 5 cyclic nucleotide phosphodiesterase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Benign prostatic hyperplasia; Erectile dysfunction
Most Recent Events
- 19 Feb 2022 No development reported - Phase-III for Benign prostatic hyperplasia in South Korea (unspecified route)
- 19 Feb 2022 No development reported - Phase-III for Erectile dysfunction in South Korea (unspecified route)
- 07 Feb 2019 Chemical structure information added